Malevolent greedy corporations

These are malevolent corporations that knew or should have known that their products were harmful, but suppressed dissent and usually aggressively continued to promote those products to the detriment of all humanity.

Exxon; knew about climate change in the 1980s from it's own internal research. Publicly attacked climate change and scientists trying to raise the alarm.

https://www.theguardian.com/business/2023/jan/12/exxon-climate-change-global-warming-research

DuPont; Knew Teflon was a carcinogenic 'forever chemical' from it's own employees cancer rates.

https://www.nytimes.com/2016/01/10/magazine/the-lawyer-who-became-duponts-worst-nightmare.html

Oh and update, 3M whom DuPont bought the PFOAs from, knew it was carcinogenic and buy the 1990s, that it was in everyone's blood, and hid it while also gaslighting the scientist that tried to raise awareness. 

https://www.propublica.org/article/3m-forever-chemicals-pfas-pfos-inside-story

3M (without admitting there's a problem) is exiting the fluoridated chemical market to 'innovate' something better. That's of course very similar to what Dupont did with refrigerants. 

e.g. 

Both DuPont and 3M responded to regulatory pressures by innovating new products. DuPont replaced CFCs with HCFCs and HFCs due to ozone concerns, while 3M plans to innovate as it exits PFAS manufacturing by 2025 due to environmental and health concerns. Both companies framed their transitions as opportunities for innovation and leadership in changing regulatory landscapes.In both cases, there's a perception of planned obsolescence, where companies develop "safer" alternatives as previous products face regulatory bans, especially given the prior art of their suppression of inconvenient science.

Purdue Pharma; knew it's narcotic OxyContin was habit forming but marketed it as a 'safer' alternative.

https://www.newyorker.com/magazine/2017/10/30/the-family-that-built-an-empire-of-pain

Glaxo (now GSK); knew Zantac (ranitidine) was unstable and could degrade into, or form in vitro, a known potent carcinogen from it's own internal studies. Continued aggressively selling it anyway.

https://www.bloomberg.com/news/features/2023-02-15/zantac-cancer-risk-data-was-kept-quiet-by-manufacturer-glaxo-for-40-years

More references to come and *sigh* more companies too. Shareholder primacy sucks. Maybe large corporations boards and C-suites shouldn't get personal indemnity for corporate wrongs.

Another post on how regulatory capture bankrupts trust eventually.

Comments

  1. Originally published February 2023. Updated June 2024.

    ReplyDelete

Post a Comment